tiprankstipranks
Diaceutics (DE:7DC)
FRANKFURT:7DC
Germany Market
7DC
Diaceutics
RESEARCH TOOLSreports

Diaceutics (7DC) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

7DC Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Diaceutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

7DC Stock 12 Month Forecast

Average Price Target

€2.52
▲(68.95% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Diaceutics in the last 3 months. The average price target is €2.52 with a high forecast of €2.52 and a low forecast of €2.52. The average price target represents a 68.95% change from the last price of €1.49.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","3":"€3","0.75":"€0.75","1.5":"€1.5","2.25":"€2.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.5173017,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€2.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5173017,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€2.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.5173017,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€2.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.75,1.5,2.25,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Feb<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.64,1.707484746153846,1.7749694923076922,1.8424542384615383,1.9099389846153845,1.9774237307692306,2.044908476923077,2.112393223076923,2.1798779692307693,2.2473627153846154,2.3148474615384615,2.3823322076923077,2.449816953846154,{"y":2.5173017,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.64,1.707484746153846,1.7749694923076922,1.8424542384615383,1.9099389846153845,1.9774237307692306,2.044908476923077,2.112393223076923,2.1798779692307693,2.2473627153846154,2.3148474615384615,2.3823322076923077,2.449816953846154,{"y":2.5173017,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.64,1.707484746153846,1.7749694923076922,1.8424542384615383,1.9099389846153845,1.9774237307692306,2.044908476923077,2.112393223076923,2.1798779692307693,2.2473627153846154,2.3148474615384615,2.3823322076923077,2.449816953846154,{"y":2.5173017,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.569,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.569,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.28,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.4,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.86,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.63,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.42,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 66, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.79,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 75, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.02,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 76, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.579,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.64,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€2.52Average Price Target€2.52Lowest Price Target€2.52
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:7DC
Unknown Analyst
Canaccord Genuity
Not Ranked
Canaccord Genuity
€2.52
Buy
68.95%
Upside
Reiterated
07/29/26
Diaceutics (DIUXF) Receives a Buy from Canaccord Genuity
Shore Capital Analyst forecast on DE:7DC
Unknown Analyst
Shore Capital
Not Ranked
Shore Capital
€2.11→€2.52
Buy
68.95%
Upside
Reiterated
01/15/26
Diaceutics (DIUXF) Gets a Buy from Shore Capital
Stifel Nicolaus Analyst forecast on DE:7DC
Christian Glennie
Stifel Nicolaus
Stifel Nicolaus
€2.63
Buy
76.80%
Upside
Reiterated
09/23/25
Diaceutics (DIUXF) Receives a Buy from Stifel Nicolaus
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on DE:7DC
Unknown Analyst
Canaccord Genuity
Not Ranked
Canaccord Genuity
€2.52
Buy
68.95%
Upside
Reiterated
07/29/26
Diaceutics (DIUXF) Receives a Buy from Canaccord Genuity
Shore Capital Analyst forecast on DE:7DC
Unknown Analyst
Shore Capital
Not Ranked
Shore Capital
€2.11→€2.52
Buy
68.95%
Upside
Reiterated
01/15/26
Diaceutics (DIUXF) Gets a Buy from Shore Capital
Stifel Nicolaus Analyst forecast on DE:7DC
Christian Glennie
Stifel Nicolaus
Stifel Nicolaus
€2.63
Buy
76.80%
Upside
Reiterated
09/23/25
Diaceutics (DIUXF) Receives a Buy from Stifel Nicolaus
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
ZURAZura Bio
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Diaceutics

3 Months
Christian GlennieStifel Nicolaus
Success Rate
1/9 ratings generated profit
11%
Average Return
+3.34%
reiterated a buy rating 10 months ago
Copying Christian Glennie's trades and holding each position for 3 Months would result in 11.11% of your transactions generating a profit, with an average return of +3.34% per trade.
1 Year
Christian GlennieStifel Nicolaus
Success Rate
4/9 ratings generated profit
44%
Average Return
+13.40%
reiterated a buy rating 10 months ago
Copying Christian Glennie's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +13.40% per trade.
2 Years
Christian GlennieStifel Nicolaus
Success Rate
8/9 ratings generated profit
89%
Average Return
+39.36%
reiterated a buy rating 10 months ago
Copying Christian Glennie's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +39.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

7DC Analyst Recommendation Trends

Rating
Jan 26
Feb 26
May 26
Jun 26
Jul 26
Strong Buy
2
2
2
1
2
Buy
0
0
0
0
0
Hold
66
75
76
21
24
Sell
12
15
14
3
0
Strong Sell
0
0
0
0
0
total
80
92
92
25
26
In the current month, 7DC has received 2 Buy Ratings, 24 Hold Ratings, and 0 Sell Ratings. 7DC average Analyst price target in the past 3 months is 2.52.
Each month's total comprises the sum of three months' worth of ratings.

7DC Financial Forecast

7DC Earnings Forecast

Next quarter’s earnings estimate for 7DC is -€0.03 with a range of -€0.03 to -€0.03. The previous quarter’s EPS was €0.04. 7DC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.38% of the time in the same period. In the last calendar year 7DC has Performed in-line its overall industry.
Next quarter’s earnings estimate for 7DC is -€0.03 with a range of -€0.03 to -€0.03. The previous quarter’s EPS was €0.04. 7DC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 46.38% of the time in the same period. In the last calendar year 7DC has Performed in-line its overall industry.

7DC Sales Forecast

Next quarter’s sales forecast for 7DC is €20.45M with a range of €20.45M to €20.45M. The previous quarter’s sales results were €27.89M. 7DC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year 7DC has Performed in-line its overall industry.
Next quarter’s sales forecast for 7DC is €20.45M with a range of €20.45M to €20.45M. The previous quarter’s sales results were €27.89M. 7DC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 29.50% of the time in the same period. In the last calendar year 7DC has Performed in-line its overall industry.

7DC Stock Forecast FAQ

What is DE:7DC’s average 12-month price target, according to analysts?
Based on analyst ratings, Diaceutics’s 12-month average price target is 2.52.
    What is DE:7DC’s upside potential, based on the analysts’ average price target?
    Diaceutics has 68.95% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Diaceutics a Buy, Sell or Hold?
          Diaceutics has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Diaceutics’s share price target?
            The average share price target for Diaceutics is 2.52. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €2.52 ,and the lowest forecast is €2.52. The average share price target represents 68.95% Increase from the current price of €1.49.
              What do analysts say about Diaceutics?
              Diaceutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Diaceutics?
                To buy shares of DE:7DC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.